diftalone

01/01/1976 - "Long-term controlled clinical trial of a new anti-inflammatory drug, diftalone, in rheumatoid arthritis."
12/01/1974 - "Therapeutic activity of diftalone in rheumatoid arthritis: a short-term controlled evaluation."
12/01/1974 - "Plasma levels of diftalone during treatment and their relationship with therapeutic activity in rheumatoid arthritis."
01/01/1977 - "Diftalone seems to be an effective and safe anti-inflammatory agent in the treatment of rheumatoid arthritis."
01/01/1976 - "In this long-term study, diftalone demonstrated that its effectiveness and safety in the treatment of rheumatoid arthritis are clearly comparable to those of indomethacin."

01/01/1978 - "[Verification of the effect of diftalone on the inflammation caused by subcutaneous injection of microcrystalline monosodium urate]."
05/01/1978 - "[Limitations of the isotopic evaluation of the effects of diftalone and indomethacin on inflammation induced with subcutaneous injection of microcrystals of monosodic urate]."

01/01/1977 - "Following our experience in thirty patients we suggest that diftalone can be considered a treatment of choice in patients with subacute thyroiditis. "
01/01/1977 - "During 1974 and 1975 thirty patients with subacute thyroiditis referred to us were treated with diftalone (Aladione), a new non-steroidal anti-inflammatory drug, at a daily oral dose of 750 mg. The average treatment lasted 39 days (range 15-100), the mean age of the patients was 43-5 years (range: 22-70). "
01/01/1977 - "Aladione (diftalone) in the treatment of subacute thyroiditis."

01/01/1984 - "Diftalone treatment at the highest dose was hepatotoxic and induced hepatocellular tumors in females, angiomas of the liver in males, and angiosarcomas of the liver in male and female mice. "

01/01/1984 - "Diftalone treatment at the highest dose was hepatotoxic and induced hepatocellular tumors in females, angiomas of the liver in males, and angiosarcomas of the liver in male and female mice. "